Clinical Trial Search - NASH and Fibrosis - CPL (US)

$18.00 CPLactive✓ verified live 6h ago

MaxBounty · Health & Wellness / Clinical Trials & Research · US · live 22 days · compare this product across geos & networks →

Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.

Run this offer — join MaxBounty

Clinical Trial Search - NASH and Fibrosis - CPL (US)

Should you run this?

Payout history

$15.00$20.006 Jul 202628 Jul 2026$18.00
Payout unchanged since we first saw this offer on 6 Jul 2026 — tracked on every refresh.

Description

Recruiting for a clinical study evaluating an investigational injectable medication (efruxifermin) vs placebo for NASH/MASH with fibrosis. Participants receive a weekly injection with monitoring including ECGs, labs, FibroScans, and possible liver biopsies.

Conversion occurs on qualified lead submission.

Target: Adults 18–80 (any gender) in approved live GEO locations diagnosed with Non-Cirrhotic NASH/MASH and Stage 2 or 3 fibrosis. May include individuals with Type 2 diabetes or related metabolic risk factors.

Restrictions: Must answer “NO” to other liver diseases including hepatitis, alcoholic liver disease, cirrhosis, liver cancer, Wilson's disease, hemochromatosis, PBC/PSC, drug-induced liver disease, or prior liver transplant.

ALL copy and creative must be submitted for compliance approval prior to going live.

View Live GEOs

Change log (1 events)

ObservedTypeFieldOldNew
7/6/2026offer_new

Reviews (0)

No reviews yet — be the first to share your experience.

Log in or create a free account to review this offer.

Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.